Cytori Therapeutics (CYTX) Misses Q3 EPS by 2c

November 9, 2016 4:26 PM EST

Get access to the best calls on Wall Street with's Ratings Insider Elite. Get your Free Trial here.

Cytori Therapeutics (NASDAQ: CYTX) reported Q3 EPS of ($0.26), $0.02 worse than the analyst estimate of ($0.24). Revenue for the quarter came in at $2.6 million versus the consensus estimate of $2.85 million.

For earnings history and earnings-related data on Cytori Therapeutics (CYTX) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment